SEARCH 
COMPANIES
Discover the reality of companies and brands!
TRANSNATIONALE.ORG
Free and independant information on large corporations

Merck KGaA

Headquarters : Frankfurter Strasse 250 64293 Darmstadt Germany Germany web 49-6151-727-426 tel. 49-6151-727-426 email: investor.relations@merck.de analytics

Brands

name
click to compare prices
» Shop local, ethical and at the best price on Ethishop

« Ethical » rating of Merck KGaA , group Merck (famille) and subsidiaries

Fraud 4 Offshore 6
[click on the rating for the method or on the number for the data]

shareholdercountry%source
Merck (famille)Germany73Bloomberg
» More shareholders of Merck KGaA
year
business
source
2007Merck manufactures 70% of the liquid crystals for flat-faced LCD screens manufactured in the world.Les Echos
2006Third-largest generic drug maker in the world.Les Echos
subsidiarycountry%source
Esaote Spa Italia50
Serono SA Switzerland100Bloomberg
» More subsidiaries of Merck KGaA
country
address & contact : production type
incentive source
Israel Israel
Mercury Chemical Agencies Ltd :
 University of California
Monaco Monaco
:
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) AFP

  • Environmental impact

  • Human impact

year name
photo position; compensation
source
2005Römer, Mickael
See the photo of: Römer, Mickael Chairman of the Executive committee;
2003Baumhauer, Jon
See the photo of: Baumhauer, Jon Chairman of the Executive committee;
2003Becker, Michael
See the photo of: Becker, Michael Chief Financial Officer;
2003Hornef, Heinrich
See the photo of: Hornef, Heinrich Chairman of the Monitoring Committee;
2000Scheuble, Bernhard
See the photo of: Scheuble, Bernhard Chief Executive Officer;
year
employees
<>
social impact : country
source
2005
29133
2003
-320
Management Alimentaire
2002
34504
1999
32721
year
employees
<>
social impact : country
source
 4 informations, access to subscribers

  • Lobbying & corruption

  • Subsidy

  • Advertising & marketing

yearfinancial misdemeanorsalesincome source
2008   7,560,37   billion US$Les Echos
2007   7,063,5   billion Eu€Les Echos
2006   4,460,98   billion Eu€Les Echos
2005   5,90,66   billion Eu€
2005 Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said.     Canadian Press
2005 Its subsidiary, Generics UK, settled with the NHS over claims that it had helped operate a cartel on generic drugs. The company had been accused of working to artificially inflate the price of certain antibiotics and of ulcer medicine Zantac. The company has paid £12m to settle the claims without admission of liability.     The Telegraph
2003   7,20,21   billion Eu€
2002   7,830,56   billion US$
2002 market-sharing and price-fixing cartels affecting vitamin products in Europe : 9,24 million euros fine.     Commission Européenne
2002 Entente pour fixer le prix de la méthylglucamine entre 1990 et 1999: acquitté pour avoir dénoncé l'entente.     Les Echos
2001   6,670,56   billion US$
2000   6,350,2   billion US$
1999   5,350,32   billion Eu€
yearfinancial misdemeanorsalesincomeassetsbuybacksource
 13 informations, access to subscribers


Bookmark and Share    en español  en français  in italiano
translate this page in arabic chinese dutch german japanese korean russian
Legal notice © T&C 1999-2010
 CONTRIBUTIONS